Welcome to Bioplatforms Australia

We provide access to 'omics technologies in support of all life science researchers working across human health, agriculture, biodiversity and industry. Bioplatforms is enabled by the Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS). Read More

Projects

Australian Fish Genomics Initiative

The Australian Fish Genomics Initiative is building a foundation of referential biomolecular data to advance knowledge of Australia’s fish species and support critical research and management strategies.

Find out more

Ricin Genomics and Global Origins Initiative

Aligned with the SABRE Alliance's mission to enhance biological threat preparedness, this collaborative effort between defence, industry, and academia seeks to leverage existing sovereign technologies, enabled by NCRIS, to provide immediate decision support tools and develop innovative solutions tailored to national security challenges.

Find out more

Integrated Pest Management Omics Initiative

Advancing Australia’s Knowledge of Insects for Integrated Pest Management

Find out more

Australian Avian Genomics Initiative

The Australian Avian Genomics Initiative is building a foundation of genomic data to advance our understanding of Australia’s unique native birds species.

Find out more
All Projects

News & Media

Annual Report 2024

Bioplatforms is committed to supporting the Australian life sciences community through a diverse access program, provision of targeted infrastructure requirements, and making integrated capability available to initiatives of breadth, scale and complexity in a way that is not readily achievable through other mechanisms.

Read more

Australian Fish Genomics Initiative: 2024 Request for Partnership Now Open

Bioplatforms Australia, in collaboration with Minderoo Foundation, is pleased to announce the opening of the 2024 Request for Partnership for the Australian Fish Genomics Initiative.

Read more

EMBL Australia joins NCRIS Health Group to enhance collaborative health research

Bioplatforms Australia is proud to collaborate with EMBL Australia and our national research partners in advancing health research for Australia.

Read more

Major breakthrough in type 1 diabetes: PromarkerD predicts kidney disease

Proteomics International Laboratories' Promarker D test effectively forecasts renal decline in patients with type 1 diabetes.

Read more
All News & Media

Events

All Events